NIH and the biomedical research enterprise have a long history of International collaborations with rules of engagement that allow science to advance while also protecting intellectual capital and proprietary information of the participating countries. These rules of engagement also are designed to limit bias in the design, conduct, and reporting of NIH-supported research.
- The integrity of the research enterprise rests upon core principles and values.
- Principled international collaboration and foreign contributions are critical to the success of the U.S. research enterprise. • Some individuals and foreign governments violate core principles of integrity and pose risks to research security.
- Hidden diversions of intellectual property weaken the U.S. innovation base and threaten our security and economic competitiveness.
- The U.S. Government is taking deliberate steps to address risks to research security and integrity while maintaining an open and collaborative enterprise.
Annals of Internal Medicine issues a correction about researcher’s undisclosed conflict of interest linking chief researcher to the meat industry.
Foreign governments and corporations could profit from American academic institutions’ failure to safeguard taxpayer-funded biomedical research, according to a set of new reports from a federal watchdog.
News reports have raised concerns about foreign threats to the United States biomedical research enterprise.
NIH awards more than 70 percent of its $37 billion budget to universities and other extramural grantee institutions (institutions). Identifying and managing investigators' financial conflicts of interest (financial conflicts) is critical to safeguarding the integrity of NIH-funded research.
A researcher at the University of Kansas (KU) was indicted today on federal charges of hiding the fact he was working full time for a Chinese university while doing research at KU funded by the U.S. government.
The intent of this notice is to remind the extramural community about the need to report foreign activities through documentation of other support, foreign components, and financial conflict of interest to prevent scientific, budgetary, or commitment overlap.
An aggressive effort by the National Institutes of Health (NIH) to enforce rules requiring its grantees to report foreign ties is still gathering steam. But it has already had a major impact on the U.S. biomedical research community.
Memorial Sloan Kettering Cancer Center has come under fire for its stake in an artificial intelligence start-up founded by three researchers from the center. Several individuals who hold leadership positions at Sloan Kettering also hold equity in the new venture.
September 9, 2018 - New York Times - The chief executive of Memorial Sloan Kettering Cancer Center sent an email to all staff members on Sunday saying that the institution and its faculty “need to do a better job” of disclosing their relationships with the drug and health care industries.
The importance of monitoring use of SBIR/STTR funds has come into sharp relief at Purdue University, where a professor and his wife were indicted this week by a grand jury for allegedly defrauding the National Science Foundation, according to an announcement from the U.S. Attorney for the Northern District of Indiana.
The Physician Payments Sunshine Act (PPSA) requires health care product manufacturers to report to the federal government payments more than $10 to physicians. Bringing unprecedented transparency to medicine, PPSA holds great potential for enabling medical stakeholders to manage conflicts of interest (COI) and build patient trust—crucial responsibilities of medical professionalism.
(CNN) - Dr. Brenda Fitzgerald, director of the US Centers for Disease Control and Prevention, resigned Wednesday, a day after Politico reported Fitzgerald's purchase of tobacco stock after she took the position at the nation's top public health agency.
One physician had his prescription pad taken away after he repeatedly failed tests assessing his competency. Another was banned from treating mentally ill inmates and accused of endangering nursing home patients by prescribing excessive dosages of medications. At least three others had criminal convictions for illegal prescribing.
The scientific community is paying increasing attention to the quality practices of journals and publishers. NIH recently released a Guide notice...
CNN - A leading advocacy group for Alzheimer's patients has stopped accepting funding from a Southern California drugmaker following a CNN investigation into the company that sparked a government probe.
The scramble for government funding on the university level is a bare-knuckle competitive business. Careers — and fortunes — are often tied directly to getting the right grant at the right time.
An investigation of financial misdeeds at an Idaho State University research and innovation center has cost the director of the center his job, and maybe more as the findings are now with the local prosecutor’s office.
from The New York Times —Dr. Carlo Croce was repeatedly cleared by Ohio State University, which reaped millions from his grants. Now, he faces new whistle-blower accusations.
from Brookings Institute — OGE Director Walter Shaub asks Trump to do more to resolve conflicts of interest. Walter M. Shaub, Jr., Director of U.S. Office of Government Ethics announces that Donald Trump’s attempts to resolve his conflicts of interest are inadequate, adding that divesture is not too high a price to pay to be president of the United States of America.
From The New York Times —Donald J. Trump’s global business empire will create an unprecedented number of conflicts of interest for a United States president, experts in legal ethics say.
From The New York Times - WASHINGTON — Just a few blocks down Pennsylvania Avenue from the White House sits the Trump International Hotel, one of the newest luxury additions to President-elect Donald J.
From The New Yorker —"Are you planning on putting your assets in a blind trust should you become President?” the Fox Business Network anchor Maria Bartiromo asked Donald Trump during a Presidential-primary debate in South Carolina, in January.
U of Maryland finds numerous problems related to conflicts of interest in a controversial press release about a brand of chocolate milk and treatment of concussions.
A JAMA journal has quickly issued a correction for a 2016 paper after the author failed to mention several relevant conflicts of interest.
The goal of this course is to go step-by-step through the process of submitting a COI disclosure in CoeusLite in order to gain familiarity with the process and the type of information investigators are being asked to provide and why.
A former research scientist at the University of California at San Diego and his corporation admitted to illegally obtaining millions of dollars in government grants and contracts, the U.S. Department of Justice announced.
Lehigh University engineering professor Yujie Ding and his wife, Yuliya Zotova, appeared to be talented researchers dedicated to advancing science, jurors in their federal fraud trial said.
A former professor at the University of Colorado (CU) has been arrested on suspicion of launching a company to sell marked-up lab equipment to the CU-Boulder campus.
The NSF has suspended millions in research grants to UConn after revelations that two professors used more than $250,000 in grant money for purchases from a company they control.
Vermont officials ignored "obvious signs" of problematic billing by health care economist Jonathan Gruber.
For years, politicians wanting to block legislation on climate change have bolstered their arguments by pointing to the work of Wei-Hock Soon.
A former high-profile electrical engineering professor has been indicted on racketeering charges, nearly five years after his career at the Georgia Institute of Technology collapsed over a wireless chip start-up he founded.
A Morgan State University professor was convicted Tuesday in connection with a scheme to defraud the National Science Foundation and his students.
Critics say doctors who conduct a clinical trial while accepting personal payments from the company sponsoring the study can feel beholden to the drug maker.
At a memorial service held last month in her favorite classroom, Patricia Buffler was hailed as a champion of children.
Dr. Laskar’s downfall is an extreme illustration of the misunderstandings — and legal risks — that academics-turned-entrepreneurs have to navigate as they try to turn classroom concepts into successful companies.
Together with a band of far-flung researchers and activists, Peter Doshi is trying to unearth data from clinical trials — complex studies that last for years and often involve thousands of patients across many countries — and make it public.
Manhattan U.S. Attorney and FBI Assistant Director in Charge Announce Criminal Complaint Against Three New York-Based University Researchers for Conspiring to Receive Bribes from a Chinese Company and a Chinese Government-Supported Research Institute
President Obama expressed great confidence when he nominated Ernest Moniz, an MIT professor, to be secretary of energy, saying the renowned physicist could balance scientific rigor with the demands of private industry and knows that “we can grow our economy while still taking care of our air, our
Ethics officials are reviewing allegations that two of state's top environmental regulators violated conflict-of-interest rules by regulating companies in which they own stock.